Provided by Tiger Trade Technology Pte. Ltd.

Milestone Pharmaceuticals Inc.

1.06
+0.02502.43%
Pre-market: 1.05-0.0050-0.47%07:41 EDT
Volume:1.92M
Turnover:2.00M
Market Cap:130.82M
PE:-1.56
High:1.07
Open:1.07
Low:1.03
Close:1.03
52wk High:3.06
52wk Low:1.00
Shares:124.00M
Float Shares:106.47M
Volume Ratio:0.98
T/O Rate:1.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6748
EPS(LYR):-0.7517
ROE:-35522.62%
ROA:-42.78%
PB:7.18
PE(LYR):-1.40

Loading ...

Milestone Starts Phase 3 Trial of Nasal Spray for Atrial Fibrillation With Rapid Heart Rate

MT Newswires Live
·
Aug 21

Milestone Pharmaceuticals enrolls first patient in ReVeRA-301 pivotal trial

TIPRANKS
·
Aug 21

Milestone Pharmaceuticals Enrolls First Patient in Phase 3 ReVeRA-301 Trial of Etripamil Nasal Spray for AFib-RVR

Reuters
·
Aug 21

Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (Afib-Rvr)

THOMSON REUTERS
·
Aug 21

Milestone Pharmaceuticals: Currently Pursuing Single-Study Supplemental New Drug Application (Snda) Registration Pathway for Treatment of Afib-Rvr

THOMSON REUTERS
·
Aug 21

Cantor starts Milestone Pharmaceuticals at Overweight, sees 200% upside

TIPRANKS
·
Aug 20

Milestone Pharmaceuticals Price Target Announced at $3.00/Share by Cantor Fitzgerald

Dow Jones
·
Aug 20

Milestone Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Canada's Milestone Pharma Misses Q2 Product Revenue Expectations

Reuters
·
Aug 12

Milestone Pharmaceuticals Q2 Income from Operations USD -25.63 Million

THOMSON REUTERS
·
Aug 12

Milestone Pharmaceuticals Q2 Revenue USD 559 Thousand VS. Ibes Estimate USD 816.7 Thousand

THOMSON REUTERS
·
Aug 12

Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Aug 12

Milestone Pharmaceuticals Q2 FY26 Net Loss Widens 120.7% to $28.61 Million

Reuters
·
Aug 12

Milestone Pharmaceuticals Q2 EPS $(0.21) Misses $(0.20) Estimate, Sales $559.000K Miss $816.667K Estimate

Benzinga Earnings
·
Aug 12

Milestone Pharmaceuticals Inc Expected to Post a Loss of 19 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Milestone Pharmaceuticals Schedules Q2 Financial Results Call and Business Update

Reuters
·
Aug 05

Analysts’ Top Healthcare Picks: AgomAb Therapeutics NV ADR (AGMB), Milestone Pharmaceuticals (MIST)

TIPRANKS
·
Jul 23

Milestone Pharma Grants 288,000 Inducement Stock Options at $1.32/share

Reuters
·
Jul 03

Milestone Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 03

Alpha Cognition elects Robert Wills as board chairman

Reuters
·
Jun 23